NASDAQ

Adaptimmune Announces New Vice President of Business Development, Wenyong Wang

PHILADELPHIA and OXFORD, United Kingdom, April 18, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

INNATE PHARMA: New preclinical data further supporting the development of IPH4301 presented at the AACR meeting

First-in-class anti-MICA/B therapeutic antibody; New data demonstrate dual mechanism of action of IPH4301, including ...